IL4 and neoplasm: The top 5 upregulated signatures (Fig. 2B) included genes pertaining to the IL4-mediated monocytes differentiation (GSE16385 signature), myelo-monocytic differentiation and immunoregulatory activity of tumor-induced myeloid suppressor cells (GSE21927 signature), response of endothelial cells to interferon α, β, and γ (GSE3920 signature), and PBMCs immune dysregulation in type I and II diabetes (GSE9006).